T-Knife Therapeutics

T-Knife Therapeutics

  • Founded: 2018
  • Location: Berlin, Germany
  • Employee range: 50 - 200
  • Clinical stage: Clin1/Clin2
  • Therapy area: Solid tumors
  • Drug types: ONC
  • Lead product: TK-8001
  • Product link: https://www.t-knife.com/pipeline/
  • Funding: $110M B Jul 2021; $78M A Aug 2020
  • Investors: Versant Ventures



job board

Short description:

TCR Cell Therapies

Drug notes:

TK-2504 Clin0 solid tumors; TK-1412 RD oncology; TK-1112 RD oncology; TK-0118 RD oncology

Long description:

Contact us to add description: recruit@workinbiotech.com


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com